• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结肠癌中淋巴结微转移检测的预后价值

Prognostic value of the detection of lymph node micrometastases in colon cancer.

作者信息

Bosch Roig Carlos E, Roselló-Sastre Ester, Alonso Hernández Sonia, Almenar Cubells Daniel, Grau Cardona Enrique, Camarasa Lillo Natalia, Bautista Daniel, Molins Palau Carmen

机构信息

Medical Oncology Unit, Dr. Peset University Hospital, Valencia, Spain.

出版信息

Clin Transl Oncol. 2008 Sep;10(9):572-8. doi: 10.1007/s12094-008-0252-9.

DOI:10.1007/s12094-008-0252-9
PMID:18796374
Abstract

INTRODUCTION AND OBJECTIVES

A study is made of the clinical repercussions of occult metastases-micrometastases (MMs+)-or isolated tumour cells (ITCs+) in the lymph nodes of patients with stage IIA and IIB colon adenocarcinoma initially considered as corresponding to N0.

MATERIAL AND METHODS

A retrospective study of 39 patients with stage IIA and IIB (T3-T4 N0 M0) colon adenocarcinoma, subjected to similar surgical and adjuvant chemotherapy treatment, with long and careful follow-up (minimum: 5 years, mean: 81.7 months) was performed on their previously resected lymph nodes, with the aid of new histological and immunohistochemical (cytokeratin) sections, in order to detect MMs or ITCs. Disease-free survival (DFS) and global survival (GS) in the two groups (patients with MMs+ or ITCs+ vs. patients without MMs or ITCs) were compared at 5 years based on the corresponding Kaplan-Meier survival curves, with the Breslow test.

RESULTS

A total of 382 lymph nodes from the 39 patients (mean: 9.8; standard deviation: 6.09) were revised. MMs+ were detected in 2 cases and ITCs+ in 2 more cases on the Cytokeratin study. GS of the whole series at 5 years was 89.74% (35 patients alive) with a DFS at 5 years of 79.49% (31 patients free of disease), but the 2 cases with MMs+ were dead at 5 years, with high statistical differences between both groups (MMs+/MMs-) (p<0.0001). When comparing the group of MMs+/ITCs+ patients and the group of MM-/ITCs- patients, the DFS and GS times at 5 years were higher in the MMs-/ITCs- group (p=0.0692 and p=0.006 respectively).

CONCLUSIONS

Although the incidence of MMs+ or ITCs+ in the examined lymph nodes was low, the presence of MMs is related to a dramatic reduction in GS and DFS at 5 years. We encourage a detailed histological study of lymph nodes resected in patients with deep penetrating colon tumours in order to assure a pN0 status.

摘要

引言与目的

对最初被认为N0的IIA期和IIB期结肠腺癌患者淋巴结中的隐匿性转移灶 - 微转移灶(MMs+)或孤立肿瘤细胞(ITCs+)的临床影响进行研究。

材料与方法

对39例IIA期和IIB期(T3 - T4 N0 M0)结肠腺癌患者进行回顾性研究,这些患者接受了相似的手术和辅助化疗治疗,并对其先前切除的淋巴结进行了长期且仔细的随访(最短:5年,平均:81.7个月),借助新的组织学和免疫组织化学(细胞角蛋白)切片来检测MMs或ITCs。根据相应的Kaplan - Meier生存曲线,采用Breslow检验比较两组(MMs+或ITCs+患者与无MMs或ITCs患者)5年时的无病生存期(DFS)和总生存期(GS)。

结果

对39例患者的总共382个淋巴结(平均:9.8;标准差:6.09)进行了检查。在细胞角蛋白研究中,检测到2例MMs+,另外2例ITCs+。整个系列5年时的GS为89.74%(35例存活),5年时的DFS为79.49%(31例无疾病),但2例MMs+患者在5年时死亡,两组(MMs+/MMs-)之间存在高度统计学差异(p<0.0001)。比较MMs+/ITCs+患者组和MM-/ITCs-患者组时,MM-/ITCs-组5年时的DFS和GS时间更高(分别为p = 0.0692和p = 0.006)。

结论

尽管在所检查的淋巴结中MMs+或ITCs+的发生率较低,但MMs的存在与5年时GS和DFS的显著降低有关。我们鼓励对深部浸润性结肠肿瘤患者切除的淋巴结进行详细的组织学研究,以确保pN0状态。

相似文献

1
Prognostic value of the detection of lymph node micrometastases in colon cancer.结肠癌中淋巴结微转移检测的预后价值
Clin Transl Oncol. 2008 Sep;10(9):572-8. doi: 10.1007/s12094-008-0252-9.
2
The prognostic value of micrometastases and isolated tumour cells in histologically negative lymph nodes of patients with colorectal cancer: a systematic review and meta-analysis.结直肠癌患者组织学阴性淋巴结中微转移和孤立肿瘤细胞的预后价值:系统评价和荟萃分析。
Eur J Surg Oncol. 2014 Mar;40(3):263-9. doi: 10.1016/j.ejso.2013.12.002. Epub 2013 Dec 14.
3
Prognostic implications of occult nodal tumour cells in stage I and II colon cancer: The correlation between micrometastasis and disease recurrence.I期和II期结肠癌中隐匿性淋巴结肿瘤细胞的预后意义:微转移与疾病复发之间的相关性。
Eur J Surg Oncol. 2017 Aug;43(8):1456-1462. doi: 10.1016/j.ejso.2017.04.012. Epub 2017 May 5.
4
The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study.微转移对I-II期结肠癌患者预后和生存的影响:Enroute⊕研究
BMC Surg. 2011 May 11;11:11. doi: 10.1186/1471-2482-11-11.
5
Occult Tumour Cells in Lymph Nodes from Gastric Cancer Patients: Should Isolated Tumour Cells Also Be Considered?胃癌患者淋巴结中的隐匿性肿瘤细胞:孤立肿瘤细胞是否也应纳入考量?
Ann Surg Oncol. 2020 Oct;27(11):4204-4215. doi: 10.1245/s10434-020-08524-4. Epub 2020 May 4.
6
Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma.IIA期结直肠癌患者淋巴结中隐匿性肿瘤细胞的发生率及预后意义
Hum Pathol. 2006 Oct;37(10):1259-67. doi: 10.1016/j.humpath.2006.04.023. Epub 2006 Jul 26.
7
Isolated tumor cells in regional lymph nodes in patients with adenocarcinoma of the esophagogastric junction might represent part of true metastases.食管胃结合部腺癌患者区域淋巴结中的孤立肿瘤细胞可能代表部分真正的转移。
Hum Pathol. 2019 Nov;93:90-96. doi: 10.1016/j.humpath.2019.08.015. Epub 2019 Aug 22.
8
Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study.一步法核酸扩增(OSNA)对淋巴结阴性结肠癌进行分子分期,导致四分之一的患者在一项前瞻性、多中心的欧洲研究中出现分期上调。
Br J Cancer. 2014 May 13;110(10):2544-50. doi: 10.1038/bjc.2014.170. Epub 2014 Apr 10.
9
Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery.评价淋巴结比率(LNR)和阳性淋巴结对数优势(LODDS)在复杂结肠癌预后疗效中的价值:急诊手术中的首次研究。
World J Surg Oncol. 2018 Sep 13;16(1):186. doi: 10.1186/s12957-018-1483-6.
10
Prognostic significance of occult metastases in colon cancer.结肠癌隐匿性转移的预后意义。
Dis Colon Rectum. 2003 Feb;46(2):221-31. doi: 10.1007/s10350-004-6527-z.

引用本文的文献

1
Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival.I期和II期结肠癌患者中的孤立肿瘤细胞与无病生存期和总生存期显著较差相关。
BMC Cancer. 2016 Feb 16;16:106. doi: 10.1186/s12885-016-2130-7.
2
Prognostic Effect of Ultra-Staging Node-Negative Colon Cancer Without Adjuvant Chemotherapy: A Prospective National Cancer Institute-Sponsored Clinical Trial.无辅助化疗的超分期淋巴结阴性结肠癌的预后影响:一项美国国立癌症研究所资助的前瞻性临床试验
J Am Coll Surg. 2015 Sep;221(3):643-51; quiz 783-5. doi: 10.1016/j.jamcollsurg.2015.05.007. Epub 2015 May 18.
3

本文引用的文献

1
Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma.II期结直肠癌淋巴结微转移免疫组化检测的意义
Clin Transl Oncol. 2006 Sep;8(9):676-80. doi: 10.1007/s12094-006-0038-4.
2
Lymph node evaluation in colorectal cancer patients: a population-based study.结直肠癌患者的淋巴结评估:一项基于人群的研究。
J Natl Cancer Inst. 2005 Feb 2;97(3):219-25. doi: 10.1093/jnci/dji020.
3
The staging of colorectal cancer: 2004 and beyond.结直肠癌的分期:2004年及以后。
Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies.
近10年研究中结直肠癌患者孤立肿瘤细胞的预后意义。
Mol Clin Oncol. 2013 Jul;1(4):582-592. doi: 10.3892/mco.2013.116. Epub 2013 May 9.
4
Lymph node micrometastasis in gastrointestinal tract cancer--a clinical aspect.消化道肿瘤淋巴结微转移——临床方面
Int J Clin Oncol. 2013 Oct;18(5):752-61. doi: 10.1007/s10147-013-0577-y. Epub 2013 Jun 18.
5
Prognostic significance of histologically detected lymph node micrometastases of sizes between 0.2 and 2 mm in colorectal cancer.结直肠癌中大小在 0.2 至 2 毫米之间的组织学检测到的淋巴结微转移的预后意义。
Int J Colorectal Dis. 2013 Jul;28(7):977-83. doi: 10.1007/s00384-012-1636-y. Epub 2013 Jan 12.
6
Ex vivo localization and immunohistochemical detection of sentinel lymph node micrometastasis in patients with colorectal cancer can upgrade tumor staging.结直肠癌患者前哨淋巴结微转移的体外定位和免疫组化检测可升级肿瘤分期。
Diagn Pathol. 2012 Jun 22;7:71. doi: 10.1186/1746-1596-7-71.
7
Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?采用一步法核酸扩增(OSNA)对结肠癌患者淋巴结进行分子检测:一种新的分期方法?
Cancer. 2012 Dec 15;118(24):6039-45. doi: 10.1002/cncr.27667. Epub 2012 Jun 8.
8
Adjuvant treatment of early colon cancer with micrometastases: results of a national survey.早期微转移结肠癌的辅助治疗:全国性调查结果。
J Surg Oncol. 2012 Aug 1;106(2):119-22. doi: 10.1002/jso.23057. Epub 2012 Feb 3.
9
Impact on Prognosis of Lymph Node Micrometastasis and Isolated Tumor Cells in Stage II Colorectal Cancer.II期结直肠癌中淋巴结微转移和孤立肿瘤细胞对预后的影响
J Korean Soc Coloproctol. 2011 Apr;27(2):71-7. doi: 10.3393/jksc.2011.27.2.71. Epub 2011 Apr 30.
CA Cancer J Clin. 2004 Nov-Dec;54(6):295-308. doi: 10.3322/canjclin.54.6.295.
4
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.美国临床肿瘤学会关于II期结肠癌辅助化疗的建议。
J Clin Oncol. 2004 Aug 15;22(16):3408-19. doi: 10.1200/JCO.2004.05.063. Epub 2004 Jun 15.
5
Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients.前哨淋巴结活检在结直肠癌患者病理分期中的预后价值。
J Surg Oncol. 2004 Mar;85(3):166-70. doi: 10.1002/jso.20030.
6
Efficacy of manual dissection of lymph nodes in colon cancer resections.结肠癌切除术中淋巴结手动清扫的疗效
Mod Pathol. 2004 Apr;17(4):402-6. doi: 10.1038/modpathol.3800071.
7
Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual.孤立肿瘤细胞的分类:美国癌症联合委员会分期手册第6版的解读
Cancer. 2003 Dec 15;98(12):2740-1. doi: 10.1002/cncr.11865.
8
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.结肠癌生存率与所分析淋巴结数量的增加相关:对组间试验INT - 0089的二次调查
J Clin Oncol. 2003 Aug 1;21(15):2912-9. doi: 10.1200/JCO.2003.05.062.
9
Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3.根治性切除结直肠癌区域淋巴结中的微转移:应用抗细胞角蛋白抗体AE1/AE3的免疫组织化学研究
Colorectal Dis. 2003 Mar;5(2):164-8. doi: 10.1046/j.1463-1318.2003.00414.x.
10
The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined.T3N0期结肠癌的预后取决于所检查淋巴结的数量。
Ann Surg Oncol. 2003 Jan-Feb;10(1):65-71. doi: 10.1245/aso.2003.03.058.